Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Cell Science Systems announced the launch of Gut Health Profile (GHP), a blood test profile that evaluates gastrointestinal (GI) health and risks on a genetic, antibody, and cellular level. The GHP may aid physicians in determining risk of celiac and other GI conditions, and in identifying disease-triggering foods besides gluten.
The GHP determines the genetic factors necessary for developing celiac disease: HLA-DQ2.5 and HLA-DQ8. The test’s high negative predictability implies that if the patient doesn’t have either or both of the genetic factors, the chances of developing celiac disease are slim to none.
The GHP also quantitatively shows whether the patient is deficient in protective antibodies (eg, IgA) or if other types of antibodies indicative of disease are present. This analysis can help physicians differentiate between celiac disease, ulcerative colitis, and Crohn’s disease, which may all present with similar symptoms.
RELATED: Entyvio Injection Approved for UC, Crohn’s Disease
The ALCAT test assesses food and chemical sensitivity and intolerance to help identify grains and other foods that should be considered for avoidance due to inflammatory cellular reactions.
Researchers will also start a clinical trial evaluating the benefits of an Alcat-based diet on patients with irritable bowel syndrome.
For more information call (800) 872-5228 or visit Alcat.com.
